FdaApplication
ANDA 215004
Identifiers
- fda_app_no: ANDA215004
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2025-02-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE | EQ 2% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product